Clearstead Advisors’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.5K Buy
961
+72
+8% +$4.42K ﹤0.01% 1463
2026
Q1
$58K Sell
889
-210
-19% -$14.9K ﹤0.01% 1247
2025
Q4
$76.3K Buy
1,099
+57
+5% +$4K ﹤0.01% 1217
2025
Q3
$72.4K Sell
1,042
-31
-3% -$2.21K ﹤0.01% 1157
2025
Q2
$80.2K Buy
1,073
+38
+4% +$2.94K ﹤0.01% 1133
2025
Q1
$83.9K Sell
1,035
-2,112
-67% -$184K ﹤0.01% 1029
2024
Q4
$280K Sell
3,147
-21
-0.7% -$2.12K ﹤0.01% 749
2024
Q3
$365K Sell
3,168
-817
-21% -$85.5K 0.01% 653
2024
Q2
$379K Buy
3,985
+3,185
+398% +$287K 0.01% 606
2024
Q1
$75.8K Hold
800
﹤0.01% 663
2023
Q4
$70.4K Hold
800
﹤0.01% 662
2023
Q3
$68.5K Hold
800
﹤0.01% 636
2023
Q2
$74.7K Sell
800
-34
-4% -$3.2K ﹤0.01% 640
2023
Q1
$83.1K Buy
834
+34
+4% +$3.46K 0.01% 546
2022
Q4
$79.3K Hold
800
0.01% 547
2022
Q3
$70K Hold
800
0.01% 544
2022
Q2
$73K Sell
800
-32
-4% -$3.02K 0.01% 545
2022
Q1
$90K Buy
832
+32
+4% +$3.09K 0.01% 570
2021
Q4
$93K Buy
+800
New +$94K 0.01% 541

Other funds holding EXPO

Clearstead Advisors's EXPO Position: Q2 2026 in Review

Clearstead Advisors increased its Exponent (EXPO) stake by 8.1% in Q2 2026, buying an estimated $4.42K and bringing the position to 961 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

Clearstead Advisors first reported a position in EXPO in Q4 2021 and has held it in 19 quarters since. The position peaked at $379K in Q2 2024. 341 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.

  • Clearstead Advisors held 961 shares of Exponent worth $56.5K as of Q2 2026.
  • Clearstead Advisors bought 72 Exponent shares in Q2 2026, an estimated $4.42K.
  • Exponent made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1463 holding.
  • Clearstead Advisors first reported a position in Exponent in Q4 2021 and has held it in 19 quarters since.
  • Clearstead Advisors's Exponent position peaked at $379K in Q2 2024.
  • 341 funds tracked by Wall St. Rank held Exponent as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.